Clinical Trials Browser

Phase 3 × Breast Neoplasms × Ramucirumab × Clear all

NCT00703326 2021-12-06

Phase III Study of Docetaxel + Ramucirumab or Placebo in Breast Cancer

Phase 3 Completed

1,144 enrolled 19 charts

Breast Neoplasms